1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody
    Meeting Abstract

    Schindler, K.; Harmankaya, K.; Postow, M. A.; Frantal, S.; Bello, D.; Ariyan, C. E.; Michielin, O. A.; Hoeller, C.; Pehamberger, H.; Wolchok, J. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of everolimus and sorafenib for the treatment of metastatic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Lipson, B. L.; Kurz, S.; Fagin, J. A.; Pfister, D. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Genome sequencing of multiple primary tumors to reveal underlying germline cancer susceptibility
    Meeting Abstract

    Schrader, K. A.; Stratton, K. L.; Murali, R.; Laitman, Y.; Cavallone, L.; Offit, L.; Wen, Y. H.; Shah, S.; Rau-Murthy, R.; Manschreck, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I dose-escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) administered in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (Pts) with advanced refractory solid tumors
    Meeting Abstract

    Sanbom, R. E.; Sharfman, W. H.; Segal, N. H.; Hodi, F. S.; Wolchok, J. D.; Urba, W. J.; Fox, B. A.; Topalian, S. L.; Pardoll, D. M.; Covello, K. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prognostic implication of KIT mutations in melanoma
    Meeting Abstract

    Roth, K. G.; Zabor, E. C.; Colgan, M. N.; Wolchok, J. D.; Chapman, P. B.; Schwartz, G. K.; Panageas, K. S.; Carvajal, R. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical efficacy and safety of lambrolizumab (MK-3475, Anti-PD-1 monoclonal antibody) in patients with advanced melanoma
    Meeting Abstract

    Ribas, A.; Robert, C.; Daud, A.; Hodi, F. S.; Wolchok, J. D.; Kefford, R.; Patnaik, A.; Hwu, W. J.; Weber, J. S.; Joshua, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations
    Meeting Abstract

    Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Needs assessment and utilization of an educational workshop and support group for Lynch syndrome patients
    Meeting Abstract

    Rau-Murthy, R.; Anrig, C.; Glogowski, E.; Salo-Mullen, E. E.; Fleischut, M. H.; Sarrel, K.; Corines, M.; Niehaus, K.; Robson, M. E.; Markowitz, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pharmacodynamic effect of ipilimumab on absolute lymphocyte count (ALC) and association with overall survival in patients with advanced melanoma
    Meeting Abstract

    Postow, M. A.; Chasalow, S. D.; Yuan, J.; Kuk, D.; Panageas, K. S.; Cheng, M.; Shahabi, V.; Berman, D. M.; Wolchok, J. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT)
    Meeting Abstract

    Pilewskie, M. L.; Ho, A. Y.; Orell, E.; Stempel, M.; Chen, Y.; Eaton, A.; Patil, S.; Morrow, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save